Phio Pharmaceuticals

PHIO

Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Insider trades and stock quote 2024-2026

All insider trades at Phio Pharmaceuticals

Subscribe RSS
Date Type Insider Position Ø-Price Volume
9/24/2026 Buy Bradford, Patricia A. Director $1.0 $6,583
9/22/2026 Buy Bitterman, Robert J. Chairman, Pres. & CEO $1.0 $2,058
9/15/2026 Buy Bradford, Patricia A. Director $1.0 $12,360
8/19/2026 Buy Plott, Ronald Todd Director $1.1 $17,100
8/18/2026 Buy Bitterman, Robert J. Chairman, Pres. & CEO $1.1 $10,600
6/26/2026 Buy Bitterman, Robert J. Chairman, Pres. & CEO $1.0 $9,900
12/31/2025 Buy Bitterman, Robert J. Chairman, Pres. & CEO $1.0 $5,150
12/23/2025 Buy Bitterman, Robert J. Chairman, Pres. & CEO $1.0 $5,100
11/21/2025 Buy Bitterman, Robert J. Chairman, Pres. & CEO $1.1 $5,700
11/18/2025 Buy Bitterman, Robert J. Chairman, Pres. & CEO $1.3 $6,350
6/10/2025 Buy Ferrara, Robert L. Director $2.4 $6,050
6/10/2025 Buy Bitterman, Robert J. Chairman, Pres & CEO $2.4 $4,840
6/9/2025 Buy Bitterman, Robert J. Chairman, Pres & CEO $2.8 $4,125
5/22/2025 Buy Bitterman, Robert J. Chairman, Pres & CEO $1.8 $2,136
5/21/2025 Buy Bitterman, Robert J. Chairman, Pres & CEO $1.8 $5,310
5/20/2025 Buy Ferrara, Robert L. Director $1.8 $4,550
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)